Fuisz and Intelligent Polymers in cardio link-up:
This article was originally published in Clinica
Fuisz Technologies' Irish subsidiary, Fuisz International, is to collaborate with Intelligent Polymers to develop a controlled release cardiovascular product which will use Fuisz's Ceform drug delivery technology and controlled absorption. They are planning a definitive further agreement to apply for approvals in the US and to market the device following the product's evaluation.
You may also be interested in...
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.
The US Food and Drug Administration posted two device-related closeout letters in November.
Jazz and PharmaMar need to see what further data will be needed to convert their FDA authorization into a full approval following disappointing results in the ATLANTIS Phase III trial.